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Aim: to investigate the efficacy of a single ultrasonic scan at age 65 to identify patients at risk from ruptured abdominal
aortic aneurysm (AAA).
Method: a total of 6058 men aged 64–81 were recruited to a randomised trial, and 3000 were invited to attend a single
screening test. An additional population of 1011 men was offered screening as they reached age 65. If a normal aorta
was identified in this sub-group, further scans were offered at two-yearly intervals. Follow up and treatment of those
identified as having an aortic dilatation of 3 cm or greater was undertaken. All subject groups were monitored for deaths
occurring over the study period, and date and cause of death were recorded.
Results: a total of 2212 men attended screening in the randomised trial; the overall compliance was 74%, and prevalence
of AAA was 7.7%. Compliance decreased, and prevalence increased, with age. Mortality from ruptured AAA was reduced
by 68% at 5 years (screened group compared to the age-matched control population), and by 42% in the study arm
(screened and refusers) compared with controls. The benefit persisted at ten years (53% and 21% respectively). Of the
uncontrolled sample of 1011 men offered a scan at age 65, 681 attended and 649 of these were found to have a normal
aortic diameter; re-screening demonstrated new aneurysm development in 4% over ten years. The aortic diameters of the
new AAAs were under 4 cm and would therefore have a low risk of rupture.1 Mortality from rupture in all those with
an initially normal aortic diameter was low, at 1 case per 1000 scans over ten years.
Conclusion: screening once for AAA at age 65 can identify the majority of AAA that are of clinical significance and
can identify a large population at low risk from rupture who do not require surveillance. This policy has been effective
when combined with selective treatment in reducing the risk of rupture for ten years in those who attend the screening
programme.
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Introduction Ruptured AAA has a poor prognosis with over half
the patients dying before reaching hospital and a peri-
Death from abdominal aortic aneurysm (AAA) (ICD operative mortality of 30–36% following emergency
441.3–6) is considered to be a common cause of sudden treatment. The overall mortality from ruptured AAA
death in men over the age of 65 in England and Wales. remains high at 80–90%4–6 despite advances in surgery.
In one year (1998), it accounted for 4684 fatalities in This contrasts with the low mortality (3–6%) for
men of all ages,2 many of which occur below the age patients who have elective surgery for AAA.7–10
of 75 years. The condition is far more common in men The benefit of planned AAA surgery depends upon
than women.3 Most aneurysms are undiagnosed and its ability to prevent death from AAA rupture, while
asymptomatic, with the patient only becoming aware causing few deaths as a result of treatment. Early
of their presence shortly before or at rupture. detection by screening is the only available way of
detecting the majority of AAA in the community. Good
compliance at initial screening and at follow up is
∗ Please address all correspondence to: R. A. P. Scott, Scott Research essential if the reduction in mortality is to be realised.Unit, CMEC, St. Richard’s Hospital, Chichester, West Sussex, PO19
4SE, U.K. The main uncertainties surrounding the benefit of
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ultrasound screening for AAA relate to the hetero- would affect both groups. Patients in the control group
were subject to current methods for management ofgeneity of their natural history and the mortality risk
associated with elective repair. It is essential to monitor AAA, by chance detection, and were only assessed for
cause of death. Checks were made to exclude anythe changes in the patients with small aneurysms, as
a proportion of patients who rupture could arise from subjects who had died prior to randomisation, or who
were duplicated on more than one GP list because ofa sub population with fast growing aneurysms which
infrequent screening could miss. Uncertainties exist changing doctors. Those who died after randomisation
were included.of the potential benefit of AAA screening, both in
economic terms and on health status.11,12 This investigation analysed the findings for men
only (6058), of whom 3000 were allocated to the screenA large multi-centre study is underway to examine
whether widespread AAA screening is effective in group and 3058 to the control group. Of the 2212 men
screened (74% compliance), 2042 were found to havereducing mortality from this condition, and whether
it would be an efficient use of limited health care a normal aorta. Mortality surveillance was undertaken
for up to 10 years:resources. Post-mortem studies have suggested that
ninety-five percent of deaths from ruptured AAA
(a) to compare the long-term effects of a single scanoccur at or above age 65; focussing the screening at
on the mortality from rupture in the control groupage 65 could therefore capture the vast majority who
and the group invited for screening,die of rupture and maximise the potential number of
(b) to identify the mortality from rupture in the grouplife years to be gained.
of screened normal men.We therefore decided to investigate the efficacy of
a single ultrasonographic scan at age 65 to identify
patients at risk from ruptured abdominal aortic an-
eurysm (AAA). We aimed to estimate this using three Study ii: Patients with a normal aorta at age 65
studies: firstly by means of a randomised controlled
trial offering a single scan in a group of men aged 64 A group of 1011 men who were not part of the con-
to 81; secondly a study of repeat scans of men, scanned trolled trial were invited for a scan at age 65. Of these,
normal at age 65, to ascertain the likely benefit of 681 attended and 649 men were found to have a
additional scans; and thirdly by estimation of the normal aorta. The latter group were invited to further
percentage of ruptured AAA deaths which occur in scans at 2-yearly intervals after their initial scan, to
men aged 65 and under, as a measure of the potential identify the formation of new AAA. This group was
benefit of screening at age 65. also followed for up to 10 years to identify the mortality
from rupture in this group of screened normal men.
Methods
Study iii: Patients dying from ruptured AAA
We investigated the issue of the benefit of a single
scan at age 65 using three separate studies. Some 265 consecutive patients were identified as hav-
ing died of ruptured AAA within the Chichester dis-
trict over a ten year study period, and the age at
rupture was noted.
Study i: Controlled Trial with single scan in men aged
64–81
A randomised controlled trial has been carried out in Screening technique
Chichester, starting in 1988. The study details and five
year results of this trial were published in 1995.13 15 775 At the screening appointment, the aorta was visualised
and measured using an ultrasound scanner. Bothmen and women were recruited to the trial and were
randomised to either a group invited to screening or antero-posterior and transverse measurements of aor-
tic diameter were taken and the maximum of the twoto an age and sex comparable control group. Nine
general practices took part in the study, and the date measurements was used as the defining diameter in
the primary analysis. Non-attendees were contacted aof randomisation was defined as the first scan date in
each practice. Randomisation occurred within each second time if no response was received, and invited
to arrange a further screening appointment. Clinicalgeneral practice so that a change in clinicians’ attitude
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decisions with regard to follow up were made using Results
both aortic measurements.
Patients with an enlarged aorta (3 cm or greater) Study i: Controlled trial
detected through the screening programme were re-
called for repeat ultrasound according to aortic dia- The age of men at scan ranged between 64 and 81. Of
the 3000 men randomised to screening, 2212 menmeter, annually if their aorta measured between
3.0–4.4 cm and three-monthly if the aorta was found attended the screening clinics. Compliance was 73%
overall and decreased with age (Table 1).to be between 4.5–5.9 cm. Patients were referred to a
vascular surgeon for consideration for elective repair Out of the 2212 men attending for a scan, 2042 were
identified as having a normal aorta and 170 AAAif the aortic diameter was 6.0 cm or greater, if growth
was more than 1 cm per year in either measurement, were detected (prevalence 7.7%). A trend of borderline
statistical significance (p=0.05) was noticed that pre-if symptoms developed, or if a large iliac aneurysm
was present. valence of AAA increased with age (Table 2).
Mortality in compliers was significantly lower than
in the control group at five years (risk reduction=
74%, 95% CI 25–92%) and at ten years (risk reduction=
73%, 95% CI 35–89%). However, when adjusted forMortality data
the fact that the compliers are not representative of
the general population, these reductions in risk lostThe cause of death in men from all study groups was
their significance, with estimated risk reductions oftaken from information provided by the Office of
68% (95% CI −40–93%) and 53% (95% CI −163–92%)National Statistics (ONS) based on death certification,
at five and ten years respectively. When both thoseand data supplied by the Registrars of Deaths to
who accepted and those who refused the invitationthe Local Health Authority. In cases where aortic
are compared with the controls, a 42% reduction inaneurysm was a possible cause of death, a copy of
mortality from ruptured AAA was seen at year 5. Thisthe post-mortem report was requested if available.
was reduced to 21% by year 10. See Table 3. TheseMortality data was collected over ten years.
did not reach statistical significance.
Study ii: Patients with a normal aorta
Analyses
In the group who were recruited as they reached age
Screening compliance and AAA prevalence rates were 65, 649 men were found to have an aortic diameter of
calculated. less than 3 cm scan at the initial scan. The incidence
For patients in the randomised study, mortality in of new aneurysms found when these patients were
the two arms of the trial (invited for screening and rescreened at 2 yearly intervals is shown in Table 4.
controls) was compared, and the primary outcome All the AAAs that developed were small, measuring
measure was death from AAA, based on ONS data less than 4 cm. In all cases, the original scan was
and post-mortem reports when available. The relative reviewed by a consultant radiologist, who confirmed
risk of AAA mortality was calculated using the ratio that the aorta did appear normal at that time. The
of the number of deaths from ruptured AAA in the time taken for the aorta to change from a normal to
study arm compared to the control arm, allowing for an aneurysmal scan are shown in Table 5.
the slight differences in group size. Men with a normal scan from both the controlled
Reduction in AAA mortality risk in the study group group (2042) and the uncontrolled group (649) were
compared to the control group was calculated by followed up for 10 years, and the cause of death noted.
comparing the difference in the number of AAA deaths Death from ruptured AAA occurred in only two out
per 1000 population between the two groups, and of the total of 2691 men, i.e. 0.07% (95% CI 0.02–0.30).
calculating the percentage difference compared to that
in the control group. Reduction in mortality risk in
the compliant group compared with the control group Study iii: Age at rupture
was similarly calculated, allowing for self-selection
bias, with the assumption that the same proportion of In the Chichester area over ten years, 265 men have
died from ruptured AAA, of whom only 14 (5.2%)potential refusers would exist in the control group as
in the study group using the method of Cuzick et al.14 were aged 65 and under at time of death.
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Table 1. Men included in the Chichester study.
Age group Study group Control group
in years
Invited Screened Compliance (%)
64–69 1041 801 77 1034
70–74 959 726 76 971
75–81 1000 685 69 1053
Total 3000 2212 74 3058
Compliance decreased with age (Chi2=21; p<0.001).
Table 2. Prevalence of abdominal aortic aneurysm (AAA) in the screened group.
Age group n Aortic diameter Prevalence (%)
in years >=3.0 cm
64–69 801 46 5.7
70–74 726 63 8.7
75–81 685 61 8.9
Total 2212 170 7.7
Prevalence of AAA increased with age (Chi2=5.8; p>0.05).
Table 3. Cumulative mortality in the control group and those that complied with study protocol.
Years since Control Study arm Reduction in mortality risk
Refusers Compliant Study vs control Compliant vs control
n=3058 n=788 n=2212 (confidence intervals) (confidence intervals)
1 3 2 0 32% 100%
2 3 2 1 −2% 54%
3 7 4 2 13% 61%
4 15 5 2 52% 79%
5 21 8 4 42% 74%
Chi2=1.8 Chi2=5.9; p<0.02
(−18, 72) (25, 92)
6 23 11 5 29% 78%
7 24 12 6 24% 66%
8 28 16 6 20% 70%
9 30 18 6 18% 72%
10 31 18 6 21% 73%
Chi2=0.5 Chi2=9.1
p<0.05 p<0.001
(−35, 54) (35, 89)
Total 31 18 6∗
∗Of whom 3, having met the criteria for considering elective surgery, were found to be unfit for operation.
Table 4. Repeat scans of patients with an initially normal aorta (screened 2-yearly from age 65).
Initial scan Repeat scans of ‘‘normals’’ Total
Age 65 Age 67 Age 69 Age 71 Age 73 Age 75 New AAA
AAA detected 32 11 7 6 3 0 27
No. men in sample 681 559 469 383 166 54
Prevalence 4.7% 2.0% 1.5% 1.6% 1.8% 0.0%
Cumulative prevalence 4.7% 6.3% 7.3% 8.2% 8.7% 8.7%
Discussion Our observations on patients who had a normal
aorta and were rescreened have shown that the new
The Chichester screening programme has provided a aneurysms that occurred were all under 4 cm in dia-
meter with low risk of rupture. There were ap-unique data set for the long-term assessment and study
of the outcome in patients with asymptomatic AAA. proximately 40 new aneurysms per 1000 men per ten
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Table 5. AAA development Rising 65 Group.
(a) Number of cases by size
AAA size in cm 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.8 Grand total
Number detected 10 4 4 4 2 1 1 1 27
(b) Average development time (months)
AAA size in cm 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.8 Grand total
Mean time (months) 45 61 33 48 60 85 48 72 50
years. Mortality surveillance of those with a normal Screening once at the age of 65 would therefore
appear to be an effective way of detecting the patientsscan shows a very low risk of death from rupture over
the next ten years. This is supported by the observation at risk from rupture, and to produce the best long
term benefit both in terms of reduced rupture rateof Emerton et al.15 and strongly suggests that a single
screening episode, using 3 cm as a definition of an and maximum life years gained. This observation is
supported by the findings of the Gloucester Group16AAA, is an effective method for separating those with
a high risk of rupture from those at low risk. who screened men at age 65 and showed a progressive
reduction in rupture rate of AAA as the proportion ofWe have previously reported the 5-year results of our
study with a randomised control population observed their population screened increased. Once the AAA
has been detected by screening, follow up with repeatprospectively.13 We showed a 68% reduction in death
from rupture at 5 years in those attending screening, ultrasound and planned surgical treatment based on
our criteria would appear to be an effective way toafter adjustment for self-selection bias in compliance
compared to the controls (who had existing standard reduce the risk of rupture over the subsequent 10
years.treatment after chance detection). This level of re-
duction in mortality in those who attend screening is This trial does not have the power to detect the
observed difference in mortality as being statisticallyvery similar to that found in other studies in Glou-
cester16 (66%) and Huntingdon (63%),17 who compared significant. A larger trial is underway (the Multi-centre
Aneurysm Screening Study (MASS)), which should bethe original unscreened population before screening
started and the same population after 5 years screen- sufficient in size (70 000 entered) to allow statistical
conclusions to be drawn.ing.
We now present the long term effect at 10 years
following a single scan to detect AAA. We have found
Conclusionthat in the group attending screening, the benefit
persisted at 73% at 10 years. After adjustment for
Screening once for AAA at age 65 in men can identifyselection bias, the reduction lost its significance but
the majority of AAA that are of clinical significanceremained substantial and strongly suggestive at 53%.
and can identify a large population at low risk fromWhen those who refuse the invitation to be screened
rupture who do not require surveillance. This policyare included in the ‘‘screened’’ group, this benefit is
has been effective when combined with selective treat-reduced to 42% at 5 years and 21% at 10 years which
ment in reducing the risk of rupture for ten years inis not significant. The benefit is reduced with time
those who attend the screening programme.largely because of continued rupture in those men
invited for screening but who did not attend (Table
3). It is therefore important to reduce those not at-
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